Efficacy of Trovafloxacin, a New Quinolone Antibiotic, in Experimental Staphylococcal Endocarditis Due to Oxacillin-Resistant Strains

Therapeutic options for severe infections caused by strains of oxacillin-resistant Staphylococcus aureus (ORSA) and coagulase-negative staphylococci (ORSE) are very limited. With the increasing resistance of such strains to aminoglycosides, rifampin, and currently available quinolone agents, as well...

ver descrição completa

Detalhes bibliográficos

Publicado no:	Antimicrob Agents Chemother
Principais autores:	Bayer, Arnold S., Li, Cong, Ing, Michael
Formato:	Artigo
Idioma:	Inglês
Publicado em:	American Society for Microbiology (ASM) 1998
Assuntos:	Experimental Therapeutics
Acesso em linha:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC105692/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/9661030/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.42.7.1837
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!